Kathryn Lurain - Concepedia

Author

Kathryn Lurain

National Cancer Institute ORCID

Also Known As

Chintapally, Nikita, K Lurain, K. Lurain, Kathryn A. Lurain, Kathryn Anne Lurain, Kathryn Lurain, Li, Mingjia

108

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute Center for Cancer Research National Institutes of Health Frederick National Laboratory for Cancer Research Leidos (United States)

About

Kathryn Lurain is an author at National Cancer Institute specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	73
2	Immunology	2	2	33
3	Pathology	1	1	11
4	Immunotherapy	1	1	11
5	Neurovirology	1	1	40

Kathryn Lurain

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study Thomas S. Uldrick, Priscila Gonçalves, Maher Abdul‐Hay, JAMA Oncology	2019	220
Discovery of Kaposi’s sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA Takanobu Tagawa, Shaojian Gao, Vishal N. Kopardé, Proceedings of the National Academy of Sciences	2018	192
Viral, immunologic, and clinical features of primary effusion lymphoma Kathryn Lurain, Mark N. Polizzotto, Karen Aleman, Blood	2019	130
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy Thomas S. Uldrick, Scott V. Adams, Rémi Fromentin, Science Translational Medicine	2022	97
Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases Ramya Ramaswami, Kathryn Lurain, Mark N. Polizzotto, Blood Advances	2021	68
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma Kathryn Lurain, Ramya Ramaswami, Ralph Mangusan, Journal for ImmunoTherapy of Cancer	2021	56
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium Talal El Zarif, Amin H. Nassar, Elio Adib, Journal of Clinical Oncology	2023	55
Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus–associated multicentric Castleman disease Ramya Ramaswami, Kathryn Lurain, Cody J. Peer, Blood	2020	49
Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate Kathryn Lurain, Thomas S. Uldrick, Ramya Ramaswami, Blood Lymphoid NeoplasiaAntiretroviral TherapyNeurovirologyHigh-dose MethotrexateHiv	2020	40
A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma Ramya Ramaswami, Thomas S. Uldrick, Mark N. Polizzotto, Clinical Cancer Research	2019	27

Page 1